ArticleJournal of diabetes investigation2025
The prevalence of hepatitis B infection and anti-HCV antibody in patients with diabetes mellitus.
Article in Journal of diabetes investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advance in molecular mechanisms underlying diabetes related to viral hepatitis infection.Frontiers in cellular and infection microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe liver's role in glucose metabolism and hormone regulation links liver infections to diabetes mellitus. Understanding this interaction is crucial for managing diabetes in affected patients.
objectiveGolestan Province has the highest incidence of hepatitis B virus (HBV) infection in the country. The current research aimed to assess the prevalence of HBV infection and anti-HCV antibodies among diabetic patients in the region, providing insights to improve disease management and prevention.
methodsData from 31,803 diabetic patients, collected (2019-2023) from the NAB system at Golestan University of Medical Sciences, were used to evaluate the co-occurrence of HBV infection and anti-HCV antibodies in them. Also, this study analyzed the co-occurrence of diabetes in three/two-generation CHB (Chronic Hepatitis B) patients, and recovered patients, demographic factors, liver enzyme, and viral DNA levels. Binary logistic regression was applied to identify factors associated with diabetes.
resultsHBsAg and anti-HCV antibody positivity were found in 2.52% and 0.53% of diabetic individuals, respectively. Diabetic patients with HBV infection (P-value = 0.003) or anti-HCV positivity (P-value = 0.008) had significantly lower BMIs. HBV prevalence was higher among married individuals (78.4%, P-value = 0.01) and rural residents (61.7%, P-value = 0.3). Diabetic patients with two or three generations of HBV/diabetes had higher liver enzyme levels and HBV viral loads compared to those without diabetes (P-value < 0.05).
conclusionsIn individuals with diabetes, compared to those without the disease, there was a correlation between HBV infections and altered liver function indicators, as well as HBV viral load. Additionally, familial susceptibility to HBV infection or anti-HCV antibody positivity was significant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.